nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—Mitoxantrone—sarcoma	0.204	0.291	CbGbCtD
Amsacrine—TOP2A—Epirubicin—sarcoma	0.165	0.235	CbGbCtD
Amsacrine—TOP2A—Etoposide—sarcoma	0.129	0.183	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—sarcoma	0.0877	0.125	CbGbCtD
Amsacrine—ABCB1—Dactinomycin—sarcoma	0.0305	0.0434	CbGbCtD
Amsacrine—ABCB1—Mitoxantrone—sarcoma	0.0273	0.0389	CbGbCtD
Amsacrine—ABCB1—Vincristine—sarcoma	0.0188	0.0267	CbGbCtD
Amsacrine—ABCB1—Etoposide—sarcoma	0.0172	0.0245	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—sarcoma	0.0117	0.0167	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—sarcoma	0.011	0.0158	CbGbCtD
Amsacrine—NCOA3—Validated nuclear estrogen receptor beta network—SMARCB1—sarcoma	0.0104	0.169	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 1—C21orf33—sarcoma	0.00675	0.11	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—COL18A1—sarcoma	0.00395	0.0643	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—FLI1—sarcoma	0.00382	0.0622	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00293	0.0477	CbGpPWpGaD
Amsacrine—NCOA3—myometrium—sarcoma	0.00248	0.0773	CbGeAlD
Amsacrine—NCOA3—hematopoietic system—sarcoma	0.00213	0.0664	CbGeAlD
Amsacrine—NCOA3—connective tissue—sarcoma	0.00205	0.0639	CbGeAlD
Amsacrine—NCOA3—smooth muscle tissue—sarcoma	0.00188	0.0584	CbGeAlD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—sarcoma	0.00181	0.0294	CbGpPWpGaD
Amsacrine—NCOA3—cardiac atrium—sarcoma	0.00162	0.0504	CbGeAlD
Amsacrine—NCOA3—uterus—sarcoma	0.00161	0.0501	CbGeAlD
Amsacrine—NCOA3—lymphoid tissue—sarcoma	0.0015	0.0467	CbGeAlD
Amsacrine—TOP2A—myometrium—sarcoma	0.00146	0.0453	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Epirubicin—sarcoma	0.00144	0.243	CbGdCrCtD
Amsacrine—NCOA3—tendon—sarcoma	0.00141	0.0439	CbGeAlD
Amsacrine—NCOA3—bone marrow—sarcoma	0.00137	0.0425	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—sarcoma	0.00134	0.225	CbGdCrCtD
Amsacrine—NCOA3—testis—sarcoma	0.00117	0.0364	CbGeAlD
Amsacrine—NCOA3—liver—sarcoma	0.0011	0.0344	CbGeAlD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—CXCR4—sarcoma	0.00103	0.0168	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—FOXO1—sarcoma	0.000951	0.0155	CbGpPWpGaD
Amsacrine—TOP2A—uterus—sarcoma	0.000944	0.0294	CbGeAlD
Amsacrine—NCOA3—FOXA1 transcription factor network—JUN—sarcoma	0.000872	0.0142	CbGpPWpGaD
Amsacrine—NCOA3—lymph node—sarcoma	0.000846	0.0264	CbGeAlD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000834	0.0136	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—PLCG1—sarcoma	0.00083	0.0135	CbGpPWpGaD
Amsacrine—TOP2A—tendon—sarcoma	0.000827	0.0258	CbGeAlD
Amsacrine—KCNH2—myometrium—sarcoma	0.000816	0.0254	CbGeAlD
Amsacrine—TOP2A—bone marrow—sarcoma	0.000801	0.025	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—ATF1—sarcoma	0.000789	0.0128	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MYOG—sarcoma	0.000778	0.0127	CbGpPWpGaD
Amsacrine—KCNH2—seminal vesicle—sarcoma	0.000737	0.023	CbGeAlD
Amsacrine—KCNH2—hematopoietic system—sarcoma	0.0007	0.0218	CbGeAlD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CREB1—sarcoma	0.00069	0.0112	CbGpPWpGaD
Amsacrine—TOP2A—testis—sarcoma	0.000685	0.0213	CbGeAlD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000647	0.0105	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000646	0.0105	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000623	0.0101	CbGpPWpGaD
Amsacrine—TOP2A—Vindesine—Vincristine—sarcoma	0.000603	0.102	CbGdCrCtD
Amsacrine—NCOA3—Developmental Biology—EZR—sarcoma	0.00059	0.0096	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—FOXO1—sarcoma	0.000589	0.00958	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—MDM2—sarcoma	0.000571	0.00928	CbGpPWpGaD
Amsacrine—KCNH2—cardiac atrium—sarcoma	0.000532	0.0166	CbGeAlD
Amsacrine—KCNH2—uterus—sarcoma	0.000529	0.0165	CbGeAlD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000519	0.00845	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—CTNNB1—sarcoma	0.000502	0.00816	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CCND1—sarcoma	0.000497	0.00809	CbGpPWpGaD
Amsacrine—TOP2A—lymph node—sarcoma	0.000497	0.0155	CbGeAlD
Amsacrine—NCOA3—Androgen receptor signaling pathway—JUN—sarcoma	0.000496	0.00807	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CTNNB1—sarcoma	0.000492	0.00801	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MYOD1—sarcoma	0.000481	0.00782	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000452	0.00735	CbGpPWpGaD
Amsacrine—KCNH2—bone marrow—sarcoma	0.000449	0.014	CbGeAlD
Amsacrine—NCOA3—Androgen receptor signaling pathway—SRC—sarcoma	0.000445	0.00724	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—CREB1—sarcoma	0.000427	0.00695	CbGpPWpGaD
Amsacrine—CYP2D6—hematopoietic system—sarcoma	0.000427	0.0133	CbGeAlD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000419	0.00682	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—sarcoma	0.000417	0.00678	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—MYC—sarcoma	0.000406	0.00661	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—EGFR—sarcoma	0.000398	0.00647	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—EGFR—sarcoma	0.00039	0.00635	CbGpPWpGaD
Amsacrine—KCNH2—testis—sarcoma	0.000384	0.012	CbGeAlD
Amsacrine—TOP2A—Vinorelbine—Vincristine—sarcoma	0.00038	0.0642	CbGdCrCtD
Amsacrine—TOP2A—Teniposide—Etoposide—sarcoma	0.00038	0.0641	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Etoposide—sarcoma	0.00038	0.0641	CbGdCrCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000374	0.00608	CbGpPWpGaD
Amsacrine—ABCB1—myometrium—sarcoma	0.000358	0.0111	CbGeAlD
Amsacrine—NCOA3—Developmental Biology—PTPRC—sarcoma	0.000348	0.00566	CbGpPWpGaD
Amsacrine—ABCB1—embryo—sarcoma	0.000344	0.0107	CbGeAlD
Amsacrine—NCOA3—Developmental Biology—PLCG1—sarcoma	0.00034	0.00553	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000334	0.00544	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—sarcoma	0.000334	0.00543	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000326	0.0053	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000325	0.00529	CbGpPWpGaD
Amsacrine—ABCB1—seminal vesicle—sarcoma	0.000323	0.0101	CbGeAlD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000323	0.00525	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000317	0.00516	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	0.000317	0.00516	CbGpPWpGaD
Amsacrine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000311	0.00506	CbGpPWpGaD
Amsacrine—ABCB1—hematopoietic system—sarcoma	0.000307	0.00957	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—JUN—sarcoma	0.000307	0.005	CbGpPWpGaD
Amsacrine—Vascular purpura—Epirubicin—sarcoma	0.000286	0.00144	CcSEcCtD
Amsacrine—Hepatic failure—Epirubicin—sarcoma	0.000285	0.00143	CcSEcCtD
Amsacrine—Mediastinal disorder—Etoposide—sarcoma	0.000285	0.00143	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000284	0.00462	CbGpPWpGaD
Amsacrine—Sepsis—Doxorubicin—sarcoma	0.000283	0.00142	CcSEcCtD
Amsacrine—Cardiac failure congestive—Epirubicin—sarcoma	0.000283	0.00142	CcSEcCtD
Amsacrine—Paraesthesia—Thiotepa—sarcoma	0.000281	0.00141	CcSEcCtD
Amsacrine—Alopecia—Etoposide—sarcoma	0.000279	0.0014	CcSEcCtD
Amsacrine—KCNH2—lymph node—sarcoma	0.000278	0.00867	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—SRC—sarcoma	0.000276	0.00448	CbGpPWpGaD
Amsacrine—Infection—Vincristine—sarcoma	0.000276	0.00138	CcSEcCtD
Amsacrine—Phlebitis—Doxorubicin—sarcoma	0.000275	0.00138	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000273	0.00137	CcSEcCtD
Amsacrine—Confusional state—Mitoxantrone—sarcoma	0.000272	0.00137	CcSEcCtD
Amsacrine—Decreased appetite—Thiotepa—sarcoma	0.000272	0.00137	CcSEcCtD
Amsacrine—Thrombocytopenia—Vincristine—sarcoma	0.000272	0.00136	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00027	0.00136	CcSEcCtD
Amsacrine—Decreased appetite—Dactinomycin—sarcoma	0.00027	0.00136	CcSEcCtD
Amsacrine—Fatigue—Thiotepa—sarcoma	0.00027	0.00135	CcSEcCtD
Amsacrine—Infection—Mitoxantrone—sarcoma	0.000268	0.00135	CcSEcCtD
Amsacrine—Fatigue—Dactinomycin—sarcoma	0.000268	0.00134	CcSEcCtD
Amsacrine—Pain—Thiotepa—sarcoma	0.000268	0.00134	CcSEcCtD
Amsacrine—Purpura—Epirubicin—sarcoma	0.000266	0.00134	CcSEcCtD
Amsacrine—Pain—Dactinomycin—sarcoma	0.000265	0.00133	CcSEcCtD
Amsacrine—Vascular purpura—Doxorubicin—sarcoma	0.000265	0.00133	CcSEcCtD
Amsacrine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000265	0.00133	CcSEcCtD
Amsacrine—Anorexia—Vincristine—sarcoma	0.000264	0.00133	CcSEcCtD
Amsacrine—Hepatic failure—Doxorubicin—sarcoma	0.000264	0.00132	CcSEcCtD
Amsacrine—Tachycardia—Mitoxantrone—sarcoma	0.000264	0.00132	CcSEcCtD
Amsacrine—Skin disorder—Mitoxantrone—sarcoma	0.000262	0.00132	CcSEcCtD
Amsacrine—TOP2A—Vinblastine—Vincristine—sarcoma	0.000262	0.0441	CbGdCrCtD
Amsacrine—Lethargy—Epirubicin—sarcoma	0.000262	0.00131	CcSEcCtD
Amsacrine—Cardiac failure congestive—Doxorubicin—sarcoma	0.000261	0.00131	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000261	0.00425	CbGpPWpGaD
Amsacrine—Hypotension—Vincristine—sarcoma	0.000259	0.0013	CcSEcCtD
Amsacrine—Feeling abnormal—Thiotepa—sarcoma	0.000258	0.00129	CcSEcCtD
Amsacrine—Anorexia—Mitoxantrone—sarcoma	0.000258	0.00129	CcSEcCtD
Amsacrine—Feeling abnormal—Dactinomycin—sarcoma	0.000256	0.00128	CcSEcCtD
Amsacrine—Gastrointestinal pain—Thiotepa—sarcoma	0.000256	0.00128	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000256	0.00416	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000255	0.00415	CbGpPWpGaD
Amsacrine—Anaemia—Etoposide—sarcoma	0.000254	0.00128	CcSEcCtD
Amsacrine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000254	0.00127	CcSEcCtD
Amsacrine—Hypotension—Mitoxantrone—sarcoma	0.000252	0.00127	CcSEcCtD
Amsacrine—Affect lability—Epirubicin—sarcoma	0.000252	0.00127	CcSEcCtD
Amsacrine—Paraesthesia—Vincristine—sarcoma	0.000249	0.00125	CcSEcCtD
Amsacrine—Urticaria—Thiotepa—sarcoma	0.000249	0.00125	CcSEcCtD
Amsacrine—Abdominal pain—Thiotepa—sarcoma	0.000247	0.00124	CcSEcCtD
Amsacrine—Body temperature increased—Thiotepa—sarcoma	0.000247	0.00124	CcSEcCtD
Amsacrine—Leukopenia—Etoposide—sarcoma	0.000246	0.00124	CcSEcCtD
Amsacrine—Purpura—Doxorubicin—sarcoma	0.000246	0.00124	CcSEcCtD
Amsacrine—Body temperature increased—Dactinomycin—sarcoma	0.000245	0.00123	CcSEcCtD
Amsacrine—Abdominal pain—Dactinomycin—sarcoma	0.000245	0.00123	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—STAG1—sarcoma	0.000245	0.00398	CbGpPWpGaD
Amsacrine—Mood swings—Epirubicin—sarcoma	0.000243	0.00122	CcSEcCtD
Amsacrine—Paraesthesia—Mitoxantrone—sarcoma	0.000243	0.00122	CcSEcCtD
Amsacrine—Lethargy—Doxorubicin—sarcoma	0.000242	0.00121	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—EGFR—sarcoma	0.000242	0.00393	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—FOXO1—sarcoma	0.000241	0.00393	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000241	0.00393	CbGpPWpGaD
Amsacrine—Decreased appetite—Vincristine—sarcoma	0.000241	0.00121	CcSEcCtD
Amsacrine—Dyspnoea—Mitoxantrone—sarcoma	0.000241	0.00121	CcSEcCtD
Amsacrine—Blood creatinine increased—Epirubicin—sarcoma	0.00024	0.00121	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Vincristine—sarcoma	0.000239	0.0012	CcSEcCtD
Amsacrine—Fatigue—Vincristine—sarcoma	0.000239	0.0012	CcSEcCtD
Amsacrine—Convulsion—Etoposide—sarcoma	0.000239	0.0012	CcSEcCtD
Amsacrine—Pain—Vincristine—sarcoma	0.000237	0.00119	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000236	0.00384	CbGpPWpGaD
Amsacrine—Decreased appetite—Mitoxantrone—sarcoma	0.000235	0.00118	CcSEcCtD
Amsacrine—CYP2D6—testis—sarcoma	0.000234	0.00729	CbGeAlD
Amsacrine—Affect lability—Doxorubicin—sarcoma	0.000233	0.00117	CcSEcCtD
Amsacrine—Fatigue—Mitoxantrone—sarcoma	0.000233	0.00117	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000233	0.00117	CcSEcCtD
Amsacrine—ABCB1—uterus—sarcoma	0.000232	0.00723	CbGeAlD
Amsacrine—Pain—Mitoxantrone—sarcoma	0.000231	0.00116	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000231	0.00116	CcSEcCtD
Amsacrine—Hypersensitivity—Thiotepa—sarcoma	0.00023	0.00116	CcSEcCtD
Amsacrine—Hypersensitivity—Dactinomycin—sarcoma	0.000229	0.00115	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—KRAS—sarcoma	0.000228	0.00371	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Vincristine—sarcoma	0.000227	0.00114	CcSEcCtD
Amsacrine—Confusional state—Etoposide—sarcoma	0.000227	0.00114	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—sarcoma	0.000225	0.00113	CcSEcCtD
Amsacrine—Asthenia—Thiotepa—sarcoma	0.000224	0.00113	CcSEcCtD
Amsacrine—Infection—Etoposide—sarcoma	0.000223	0.00112	CcSEcCtD
Amsacrine—Asthenia—Dactinomycin—sarcoma	0.000223	0.00112	CcSEcCtD
Amsacrine—Feeling abnormal—Mitoxantrone—sarcoma	0.000223	0.00112	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000222	0.00362	CbGpPWpGaD
Amsacrine—Blood creatinine increased—Doxorubicin—sarcoma	0.000222	0.00112	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.000222	0.00361	CbGpPWpGaD
Amsacrine—Dysphagia—Epirubicin—sarcoma	0.000221	0.00111	CcSEcCtD
Amsacrine—CYP2D6—liver—sarcoma	0.000221	0.00689	CbGeAlD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000221	0.00359	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000221	0.00111	CcSEcCtD
Amsacrine—Thrombocytopenia—Etoposide—sarcoma	0.00022	0.0011	CcSEcCtD
Amsacrine—Tachycardia—Etoposide—sarcoma	0.000219	0.0011	CcSEcCtD
Amsacrine—Body temperature increased—Vincristine—sarcoma	0.000219	0.0011	CcSEcCtD
Amsacrine—Abdominal pain—Vincristine—sarcoma	0.000219	0.0011	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—STAG1—sarcoma	0.000219	0.00356	CbGpPWpGaD
Amsacrine—Skin disorder—Etoposide—sarcoma	0.000218	0.0011	CcSEcCtD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000217	0.00354	CbGpPWpGaD
Amsacrine—ABCB1—lymphoid tissue—sarcoma	0.000216	0.00674	CbGeAlD
Amsacrine—Urticaria—Mitoxantrone—sarcoma	0.000215	0.00108	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000215	0.00349	CbGpPWpGaD
Amsacrine—Anorexia—Etoposide—sarcoma	0.000214	0.00108	CcSEcCtD
Amsacrine—Diarrhoea—Thiotepa—sarcoma	0.000214	0.00107	CcSEcCtD
Amsacrine—Abdominal pain—Mitoxantrone—sarcoma	0.000214	0.00107	CcSEcCtD
Amsacrine—Body temperature increased—Mitoxantrone—sarcoma	0.000214	0.00107	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000214	0.00107	CcSEcCtD
Amsacrine—Diarrhoea—Dactinomycin—sarcoma	0.000212	0.00107	CcSEcCtD
Amsacrine—Pancytopenia—Epirubicin—sarcoma	0.00021	0.00106	CcSEcCtD
Amsacrine—Hypotension—Etoposide—sarcoma	0.00021	0.00105	CcSEcCtD
Amsacrine—Dizziness—Thiotepa—sarcoma	0.000207	0.00104	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—sarcoma	0.000205	0.00103	CcSEcCtD
Amsacrine—Hypersensitivity—Vincristine—sarcoma	0.000204	0.00103	CcSEcCtD
Amsacrine—Paraesthesia—Etoposide—sarcoma	0.000202	0.00101	CcSEcCtD
Amsacrine—Weight increased—Epirubicin—sarcoma	0.000202	0.00101	CcSEcCtD
Amsacrine—Weight decreased—Epirubicin—sarcoma	0.0002	0.00101	CcSEcCtD
Amsacrine—Dyspnoea—Etoposide—sarcoma	0.0002	0.00101	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—KDR—sarcoma	0.0002	0.00325	CbGpPWpGaD
Amsacrine—Hypersensitivity—Mitoxantrone—sarcoma	0.000199	0.000999	CcSEcCtD
Amsacrine—Asthenia—Vincristine—sarcoma	0.000199	0.000999	CcSEcCtD
Amsacrine—Vomiting—Thiotepa—sarcoma	0.000199	0.000999	CcSEcCtD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—sarcoma	0.000198	0.0334	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—sarcoma	0.000198	0.0334	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—sarcoma	0.000198	0.0334	CbGdCrCtD
Amsacrine—Infestation NOS—Epirubicin—sarcoma	0.000197	0.000992	CcSEcCtD
Amsacrine—Infestation—Epirubicin—sarcoma	0.000197	0.000992	CcSEcCtD
Amsacrine—Vomiting—Dactinomycin—sarcoma	0.000197	0.000991	CcSEcCtD
Amsacrine—Rash—Thiotepa—sarcoma	0.000197	0.00099	CcSEcCtD
Amsacrine—Dermatitis—Thiotepa—sarcoma	0.000197	0.000989	CcSEcCtD
Amsacrine—ABCB1—bone marrow—sarcoma	0.000197	0.00613	CbGeAlD
Amsacrine—Headache—Thiotepa—sarcoma	0.000196	0.000984	CcSEcCtD
Amsacrine—Rash—Dactinomycin—sarcoma	0.000196	0.000983	CcSEcCtD
Amsacrine—Decreased appetite—Etoposide—sarcoma	0.000195	0.000981	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—sarcoma	0.000195	0.000977	CcSEcCtD
Amsacrine—Renal failure—Epirubicin—sarcoma	0.000194	0.000975	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Etoposide—sarcoma	0.000194	0.000974	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—HRAS—sarcoma	0.000194	0.00316	CbGpPWpGaD
Amsacrine—Asthenia—Mitoxantrone—sarcoma	0.000194	0.000973	CcSEcCtD
Amsacrine—Fatigue—Etoposide—sarcoma	0.000194	0.000973	CcSEcCtD
Amsacrine—Jaundice—Epirubicin—sarcoma	0.000193	0.000967	CcSEcCtD
Amsacrine—Stomatitis—Epirubicin—sarcoma	0.000193	0.000967	CcSEcCtD
Amsacrine—Pain—Etoposide—sarcoma	0.000192	0.000965	CcSEcCtD
Amsacrine—Diarrhoea—Vincristine—sarcoma	0.00019	0.000953	CcSEcCtD
Amsacrine—Haematuria—Epirubicin—sarcoma	0.000188	0.000945	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—NPM1—sarcoma	0.000188	0.00306	CbGpPWpGaD
Amsacrine—Hepatobiliary disease—Epirubicin—sarcoma	0.000187	0.000938	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—sarcoma	0.000187	0.000937	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000186	0.00303	CbGpPWpGaD
Amsacrine—Nausea—Thiotepa—sarcoma	0.000186	0.000933	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—sarcoma	0.000185	0.000931	CcSEcCtD
Amsacrine—Feeling abnormal—Etoposide—sarcoma	0.000185	0.00093	CcSEcCtD
Amsacrine—Diarrhoea—Mitoxantrone—sarcoma	0.000185	0.000928	CcSEcCtD
Amsacrine—Nausea—Dactinomycin—sarcoma	0.000184	0.000926	CcSEcCtD
Amsacrine—Agranulocytosis—Epirubicin—sarcoma	0.000184	0.000925	CcSEcCtD
Amsacrine—Gastrointestinal pain—Etoposide—sarcoma	0.000184	0.000923	CcSEcCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—sarcoma	0.000183	0.0309	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—sarcoma	0.000183	0.0309	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—sarcoma	0.000183	0.0309	CbGdCrCtD
Amsacrine—Dizziness—Vincristine—sarcoma	0.000183	0.000921	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—sarcoma	0.000183	0.000918	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—sarcoma	0.000183	0.000918	CcSEcCtD
Amsacrine—Bradycardia—Epirubicin—sarcoma	0.00018	0.000906	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—sarcoma	0.00018	0.000902	CcSEcCtD
Amsacrine—Urticaria—Etoposide—sarcoma	0.000179	0.000896	CcSEcCtD
Amsacrine—Haemoglobin—Epirubicin—sarcoma	0.000178	0.000895	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—sarcoma	0.000178	0.000894	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—sarcoma	0.000178	0.000894	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MYC—sarcoma	0.000178	0.0029	CbGpPWpGaD
Amsacrine—Abdominal pain—Etoposide—sarcoma	0.000178	0.000892	CcSEcCtD
Amsacrine—Body temperature increased—Etoposide—sarcoma	0.000178	0.000892	CcSEcCtD
Amsacrine—Haemorrhage—Epirubicin—sarcoma	0.000177	0.00089	CcSEcCtD
Amsacrine—Hepatitis—Epirubicin—sarcoma	0.000177	0.00089	CcSEcCtD
Amsacrine—Hypoaesthesia—Epirubicin—sarcoma	0.000176	0.000886	CcSEcCtD
Amsacrine—Vomiting—Vincristine—sarcoma	0.000176	0.000886	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—CREB1—sarcoma	0.000175	0.00285	CbGpPWpGaD
Amsacrine—Urinary tract disorder—Epirubicin—sarcoma	0.000175	0.000879	CcSEcCtD
Amsacrine—Rash—Vincristine—sarcoma	0.000175	0.000878	CcSEcCtD
Amsacrine—Dermatitis—Vincristine—sarcoma	0.000175	0.000877	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—sarcoma	0.000174	0.000875	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—sarcoma	0.000174	0.000875	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—sarcoma	0.000174	0.000873	CcSEcCtD
Amsacrine—Headache—Vincristine—sarcoma	0.000174	0.000873	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000173	0.000868	CcSEcCtD
Amsacrine—Vomiting—Mitoxantrone—sarcoma	0.000172	0.000862	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—sarcoma	0.000171	0.000856	CcSEcCtD
Amsacrine—Rash—Mitoxantrone—sarcoma	0.00017	0.000855	CcSEcCtD
Amsacrine—Dermatitis—Mitoxantrone—sarcoma	0.00017	0.000854	CcSEcCtD
Amsacrine—Headache—Mitoxantrone—sarcoma	0.000169	0.00085	CcSEcCtD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000169	0.00274	CbGpPWpGaD
Amsacrine—ABCB1—testis—sarcoma	0.000168	0.00524	CbGeAlD
Amsacrine—Bradycardia—Doxorubicin—sarcoma	0.000167	0.000839	CcSEcCtD
Amsacrine—Hypersensitivity—Etoposide—sarcoma	0.000166	0.000831	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—sarcoma	0.000165	0.000828	CcSEcCtD
Amsacrine—Nausea—Vincristine—sarcoma	0.000165	0.000827	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—sarcoma	0.000165	0.000826	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000164	0.00267	CbGpPWpGaD
Amsacrine—Haemorrhage—Doxorubicin—sarcoma	0.000164	0.000824	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—sarcoma	0.000164	0.000824	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—sarcoma	0.000163	0.00082	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MMP2—sarcoma	0.000163	0.00265	CbGpPWpGaD
Amsacrine—Urinary tract disorder—Doxorubicin—sarcoma	0.000162	0.000813	CcSEcCtD
Amsacrine—Asthenia—Etoposide—sarcoma	0.000161	0.000809	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—sarcoma	0.000161	0.000809	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—sarcoma	0.000161	0.000808	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—sarcoma	0.000161	0.000807	CcSEcCtD
Amsacrine—Nausea—Mitoxantrone—sarcoma	0.00016	0.000806	CcSEcCtD
Amsacrine—Mediastinal disorder—Epirubicin—sarcoma	0.00016	0.000802	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ENO2—sarcoma	0.000159	0.00259	CbGpPWpGaD
Amsacrine—ABCB1—liver—sarcoma	0.000159	0.00496	CbGeAlD
Amsacrine—NCOA3—Metabolism—HBA1—sarcoma	0.000158	0.00258	CbGpPWpGaD
Amsacrine—Arrhythmia—Epirubicin—sarcoma	0.000158	0.000795	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—CREB1—sarcoma	0.000158	0.00256	CbGpPWpGaD
Amsacrine—Alopecia—Epirubicin—sarcoma	0.000157	0.000787	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CCND1—sarcoma	0.000156	0.00254	CbGpPWpGaD
Amsacrine—Mental disorder—Epirubicin—sarcoma	0.000155	0.00078	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—sarcoma	0.000154	0.000775	CcSEcCtD
Amsacrine—Diarrhoea—Etoposide—sarcoma	0.000154	0.000772	CcSEcCtD
Amsacrine—Cardiac disorder—Doxorubicin—sarcoma	0.000152	0.000764	CcSEcCtD
Amsacrine—Angiopathy—Doxorubicin—sarcoma	0.000149	0.000747	CcSEcCtD
Amsacrine—Dizziness—Etoposide—sarcoma	0.000149	0.000746	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—PDGFRA—sarcoma	0.000148	0.00241	CbGpPWpGaD
Amsacrine—Mediastinal disorder—Doxorubicin—sarcoma	0.000148	0.000742	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—sarcoma	0.000147	0.000736	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—sarcoma	0.000146	0.00238	CbGpPWpGaD
Amsacrine—Vision blurred—Epirubicin—sarcoma	0.000145	0.00073	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—sarcoma	0.000145	0.000728	CcSEcCtD
Amsacrine—Mental disorder—Doxorubicin—sarcoma	0.000144	0.000722	CcSEcCtD
Amsacrine—Vomiting—Etoposide—sarcoma	0.000143	0.000717	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—sarcoma	0.000143	0.000717	CcSEcCtD
Amsacrine—Anaemia—Epirubicin—sarcoma	0.000143	0.000716	CcSEcCtD
Amsacrine—Rash—Etoposide—sarcoma	0.000142	0.000711	CcSEcCtD
Amsacrine—Dermatitis—Etoposide—sarcoma	0.000142	0.000711	CcSEcCtD
Amsacrine—Headache—Etoposide—sarcoma	0.000141	0.000707	CcSEcCtD
Amsacrine—Leukopenia—Epirubicin—sarcoma	0.000138	0.000694	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000138	0.00225	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000136	0.00221	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PLCG1—sarcoma	0.000135	0.0022	CbGpPWpGaD
Amsacrine—Vision blurred—Doxorubicin—sarcoma	0.000135	0.000676	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—JUN—sarcoma	0.000134	0.00218	CbGpPWpGaD
Amsacrine—Convulsion—Epirubicin—sarcoma	0.000134	0.000671	CcSEcCtD
Amsacrine—Nausea—Etoposide—sarcoma	0.000133	0.00067	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000133	0.00216	CbGpPWpGaD
Amsacrine—Anaemia—Doxorubicin—sarcoma	0.000132	0.000663	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00013	0.000655	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—sarcoma	0.000128	0.000642	CcSEcCtD
Amsacrine—Confusional state—Epirubicin—sarcoma	0.000127	0.000638	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000126	0.00206	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—sarcoma	0.000125	0.00204	CbGpPWpGaD
Amsacrine—Infection—Epirubicin—sarcoma	0.000125	0.000628	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—CTNNB1—sarcoma	0.000125	0.00203	CbGpPWpGaD
Amsacrine—Convulsion—Doxorubicin—sarcoma	0.000124	0.000621	CcSEcCtD
Amsacrine—Thrombocytopenia—Epirubicin—sarcoma	0.000123	0.000619	CcSEcCtD
Amsacrine—Tachycardia—Epirubicin—sarcoma	0.000123	0.000617	CcSEcCtD
Amsacrine—Skin disorder—Epirubicin—sarcoma	0.000122	0.000614	CcSEcCtD
Amsacrine—ABCB1—lymph node—sarcoma	0.000122	0.0038	CbGeAlD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000121	0.000606	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—sarcoma	0.00012	0.000603	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000118	0.00192	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000118	0.00192	CbGpPWpGaD
Amsacrine—Hypotension—Epirubicin—sarcoma	0.000118	0.000591	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—sarcoma	0.000118	0.00059	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000117	0.00191	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000117	0.00191	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—CREB1—sarcoma	0.000117	0.0019	CbGpPWpGaD
Amsacrine—Infection—Doxorubicin—sarcoma	0.000116	0.000581	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—sarcoma	0.000114	0.000573	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—sarcoma	0.000114	0.000571	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—JUN—sarcoma	0.000113	0.00184	CbGpPWpGaD
Amsacrine—Skin disorder—Doxorubicin—sarcoma	0.000113	0.000568	CcSEcCtD
Amsacrine—Paraesthesia—Epirubicin—sarcoma	0.000113	0.000568	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—SRC—sarcoma	0.000113	0.00184	CbGpPWpGaD
Amsacrine—Dyspnoea—Epirubicin—sarcoma	0.000112	0.000564	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—sarcoma	0.000111	0.000558	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—VEGFA—sarcoma	0.00011	0.00179	CbGpPWpGaD
Amsacrine—Decreased appetite—Epirubicin—sarcoma	0.000109	0.00055	CcSEcCtD
Amsacrine—Hypotension—Doxorubicin—sarcoma	0.000109	0.000547	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000109	0.000546	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—NRAS—sarcoma	0.000109	0.00177	CbGpPWpGaD
Amsacrine—Fatigue—Epirubicin—sarcoma	0.000109	0.000545	CcSEcCtD
Amsacrine—Pain—Epirubicin—sarcoma	0.000108	0.000541	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000106	0.00172	CbGpPWpGaD
Amsacrine—Paraesthesia—Doxorubicin—sarcoma	0.000105	0.000525	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—sarcoma	0.000104	0.000522	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—sarcoma	0.000104	0.000521	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000103	0.00168	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Epirubicin—sarcoma	0.000103	0.000517	CcSEcCtD
Amsacrine—Decreased appetite—Doxorubicin—sarcoma	0.000101	0.000509	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000101	0.000505	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—sarcoma	0.0001	0.000505	CcSEcCtD
Amsacrine—Urticaria—Epirubicin—sarcoma	0.0001	0.000502	CcSEcCtD
Amsacrine—Pain—Doxorubicin—sarcoma	9.97e-05	0.0005	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—sarcoma	9.96e-05	0.0005	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—sarcoma	9.96e-05	0.0005	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—EGFR—sarcoma	9.9e-05	0.00161	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—MDM2—sarcoma	9.69e-05	0.00158	CbGpPWpGaD
Amsacrine—Feeling abnormal—Doxorubicin—sarcoma	9.6e-05	0.000482	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—sarcoma	9.53e-05	0.000479	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	9.49e-05	0.00154	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—KRAS—sarcoma	9.35e-05	0.00152	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	9.28e-05	0.00151	CbGpPWpGaD
Amsacrine—Hypersensitivity—Epirubicin—sarcoma	9.28e-05	0.000466	CcSEcCtD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	9.28e-05	0.00151	CbGpPWpGaD
Amsacrine—Urticaria—Doxorubicin—sarcoma	9.26e-05	0.000465	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—sarcoma	9.21e-05	0.000463	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—sarcoma	9.21e-05	0.000463	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	9.1e-05	0.00148	CbGpPWpGaD
Amsacrine—Asthenia—Epirubicin—sarcoma	9.04e-05	0.000454	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	8.77e-05	0.00143	CbGpPWpGaD
Amsacrine—Diarrhoea—Epirubicin—sarcoma	8.62e-05	0.000433	CcSEcCtD
Amsacrine—Hypersensitivity—Doxorubicin—sarcoma	8.59e-05	0.000431	CcSEcCtD
Amsacrine—Asthenia—Doxorubicin—sarcoma	8.36e-05	0.00042	CcSEcCtD
Amsacrine—Dizziness—Epirubicin—sarcoma	8.33e-05	0.000418	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—IL2—sarcoma	8.1e-05	0.00132	CbGpPWpGaD
Amsacrine—Vomiting—Epirubicin—sarcoma	8.01e-05	0.000402	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—sarcoma	7.97e-05	0.0004	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—HRAS—sarcoma	7.95e-05	0.00129	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	7.95e-05	0.00129	CbGpPWpGaD
Amsacrine—Rash—Epirubicin—sarcoma	7.94e-05	0.000399	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—sarcoma	7.93e-05	0.000398	CcSEcCtD
Amsacrine—Headache—Epirubicin—sarcoma	7.89e-05	0.000396	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	7.79e-05	0.00127	CbGpPWpGaD
Amsacrine—Dizziness—Doxorubicin—sarcoma	7.71e-05	0.000387	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—sarcoma	7.48e-05	0.00122	CbGpPWpGaD
Amsacrine—Nausea—Epirubicin—sarcoma	7.48e-05	0.000376	CcSEcCtD
Amsacrine—Vomiting—Doxorubicin—sarcoma	7.41e-05	0.000372	CcSEcCtD
Amsacrine—Rash—Doxorubicin—sarcoma	7.35e-05	0.000369	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—sarcoma	7.34e-05	0.000369	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	7.32e-05	0.00119	CbGpPWpGaD
Amsacrine—Headache—Doxorubicin—sarcoma	7.3e-05	0.000367	CcSEcCtD
Amsacrine—Nausea—Doxorubicin—sarcoma	6.92e-05	0.000348	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—sarcoma	6.88e-05	0.00112	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—sarcoma	5.88e-05	0.000957	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—sarcoma	5.73e-05	0.000932	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	5.41e-05	0.000879	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—sarcoma	5.32e-05	0.000865	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—sarcoma	5.12e-05	0.000833	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—sarcoma	4.59e-05	0.000747	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	4.47e-05	0.000728	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—sarcoma	4.11e-05	0.000668	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.9e-05	0.000634	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.89e-05	0.000632	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.86e-05	0.000628	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.49e-05	0.000567	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.4e-05	0.000553	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—sarcoma	3.37e-05	0.000549	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.13e-05	0.000508	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.06e-05	0.000497	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.89e-05	0.00047	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.57e-05	0.000418	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO2—sarcoma	2.3e-05	0.000375	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HBA1—sarcoma	2.29e-05	0.000372	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO2—sarcoma	2.17e-05	0.000353	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HBA1—sarcoma	2.16e-05	0.000351	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLCG1—sarcoma	1.95e-05	0.000318	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLCG1—sarcoma	1.84e-05	0.000299	CbGpPWpGaD
